TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
Launches collaborative centre for translational research in head and neck cancer
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
The orphan drug designation by the EC is issued for drugs which are intended to treat diseases that affect fewer than five in 10,000 people in the European Union
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Subscribe To Our Newsletter & Stay Updated
